Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 GWAS of response to Peg-IFN-based therapy in chronic hepatitis B
2013-001141-14Phase 4Completed
- Sponsor
- Roche
- Start
- Jun 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pegylated interferon alpha in Chronic Hepatitis B (CHB) and hepatitis B (HBV), sponsored by Roche. Started Jun 2013; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)hepatitis B (HBV)
Beyond the preview
Go deeper on 2013-001141-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001141-14.